meridians Global.

Join us →

◇ Q3 2026 results — revenue €14.2B, +6.4% YoY ◇ meridians Global OncoTrial Phase III meets primary endpoint ◇ New regenerative agriculture pact with 42,000 farms ◇ Carbon intensity down 38% vs 2019 baseline ◇ Netherlands R&D campus opens 09 · 15 · 2026 ◇ Q3 2026 results — revenue €14.2B, +6.4% YoY ◇ meridians Global OncoTrial Phase III meets primary endpoint ◇ New regenerative agriculture pact with 42,000 farms ◇ Carbon intensity down 38% vs 2019 baseline ◇ Netherlands R&D campus opens 09 · 15 · 2026

◐ Annual Report 2026 · Now Live Netherlands · Basel · Netherlands · Singapore

Science
for a living
planet.

meridians Global is a global life sciences company operating at the intersection of human health, nutrition and the natural world — building measurable, science-led progress against the century's hardest problems.

Explore what we do → Watch the film ⏵

Live · 14 Sep 2026

€ 91.42

MRDN · Frankfurt ▲ 1.24 (+1.37%)

Countries

People

R&D €B

Scroll for the full picture

Global Revenue 2026

€ 0B

▲ 6.4% year over year

R&D Investment

€ 0B

11.5% of revenue

Lives Improved · Cumulative

0B+

Health & nutrition combined

Emissions vs 2019

−0%

On track for net-zero 2039

◐ Our Purpose

Founded in 1978 as a small crop-genetics lab in Utrecht, meridians Global today unites four scientific disciplines under one operating charter — with a single north star.

A healthier body.
A more generous field.
A quieter climate.
One company, three commitments.

01 Health

Precision therapeutics, women's health, and self-care backed by 47 years of clinical evidence.

02 Nutrition

Regenerative seed, biological crop protection and digital agronomy for the family farm.

03 Planet

Carbon-first operations, water stewardship, and open-source biodiversity tooling.

◐ Divisions

Four labs.
One outcome.

Each division is a company inside a company — with its own P&L, science council, and 10-year roadmap. Below, the ways they meet the world.

01 · Pharmaceuticals € 21.4B revenue

meridians Global
Pharma

Oncology, cardio-renal and women's health platforms. 74 molecules in pipeline, 12 in Phase III.

Explore Pharma →

02 · Crop Science € 24.9B

meridians Global
Cultiva

Regenerative seed genetics and biological crop protection — for 42,000+ smallholder farms.

03 · Consumer Health

meridians Global
Everyday

Self-care brands trusted across 118 markets. €6.5B revenue.

04 · Bio-Ventures

128

Portfolio startups since 2014

meridians Global
Ventures

Early-stage capital for synthetic biology, women's health, and climate-positive agri-tech.

05 · Digital

meridians Global
Datum

AI-native platforms for clinical trials and farm-scale agronomy. 4.1M active users.

◐ Feature · R&D 2026

The molecule
that learned
to listen.

At our Netherlands discovery campus, an AI-guided platform now designs candidate small-molecule therapies in 11 days — a process that previously took 14 months. Twelve of these molecules are in-clinic today.

Days to lead

×0

Faster than 2020

In clinic

→ Read the technical brief (PDF)

Live simulation

MRD-9714 · binding affinity 0.42 nM

Site · Netherlands-Mitte

"We asked chemistry to prove itself faster."

— Dr. Amara Okafor, Chief Scientist

02:41 · Watch the film

Step 01

Target discovery

Step 02

Generative design

Step 03

Wet-lab validation

Step 04

Clinic

◐ Where science meets life

Nine fields.
One method.

We work only where scientific evidence, industrial scale and public benefit intersect. Below, our nine active fields — filtered by outcome, not by discipline.

01 · Field

Oncology

→

Precision therapies for solid tumors and hematological cancers.

02 · Field

Women's Health

→

Contraception, hormone therapy, and reproductive medicine at scale.

03 · Field

Cardio-Renal

→

A pipeline built around chronic kidney and heart disease.

04 · Field

Regenerative Farming

→

Cover-crop systems, no-till protocols, and living soil programs.

05 · Field

Seed Genetics

→

Drought- and heat-resilient varieties, breed-by-breed.

06 · Field

Everyday Self-Care

→

Trusted OTC brands, nutrition, and dermocosmetics.

07 · Field

AI & Data Science

→

Generative chemistry, trial simulation, and farm-scale agronomy.

08 · Field

Water & Soil

→

Watershed programs and soil-microbiome science.

Emerging fields

09 · Field

Explore all →

Synthetic biology, longevity, mycology, marine agriculture.

◐ Newsroom

Recently, in the field.

Feature · Pharma

12 Sep 2026 · 8 min read

Phase III OncoTrial for MRD-2114 hits primary endpoint in advanced colorectal cancer.

Agriculture · 09 Sep

42,000 smallholder farms join meridians Global's regenerative seed compact.

Cultiva · Nairobi hub

Sustainability · 04 Sep

Site-level carbon intensity down 38% — five years ahead of schedule.

Report · ESG

◐

Corporate · 01 Sep

meridians Global names Dr. Léa Barbier as new Chief Scientific Officer.

Press release

Showing 4 of 218 stories Visit the full newsroom →

A company like ours only earns the right to exist by the outcomes it leaves behind — the patient still here five years later, the field still fertile in fifty, the child born into a climate we did not surrender.